Fig. 1.
Plasma concentrations of markers of oxidative damage (F2-isoprostanes [A] and isofurans [B]), neuronal injury (ubiquitin carboxyl-terminal hydrolase isozyme L1[C]), and blood–brain barrier disruption (S100 calcium-binding protein B [D]) during the perioperative period in patients who developed delirium and those who did not develop delirium.